EN
TR
How To Use Targeted Drugs in Metastatic Renal Cell Cancer
Abstract
In Renal cell cancer biology (RCC), with vascular endothelial growth factor and diagnosing of mammalian target of rapamycin B pathway, new options (targeted drugs) are developed in therapy. With Targeted Drugs, new period started now in the RCC treatment which has limited treatment option at one time. Then bevasizumab, temsirolimus, everolimus and pazopanib were added to workings that initially started with sunitinib and sorafenib. Although antitumoral effects of drugs are similar in these treatment options, differences are seen in clinical effects and toxicity. Therefore, early determination of adverse effects that are associated with treatment and direction of treatment will improve patient's quality of life and unnecessary dose reduction won't occur.
Keywords
Details
Primary Language
English
Subjects
-
Journal Section
-
Publication Date
September 1, 2011
Submission Date
September 1, 2011
Acceptance Date
-
Published in Issue
Year 2011 Volume: 37 Number: 3
APA
Avcı, N., & Manavoğlu, O. (2011). How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Journal of Uludağ University Medical Faculty, 37(3), 165-168. https://izlik.org/JA62JC44WJ
AMA
1.Avcı N, Manavoğlu O. How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Journal of Uludağ University Medical Faculty. 2011;37(3):165-168. https://izlik.org/JA62JC44WJ
Chicago
Avcı, Nilüfer, and Osman Manavoğlu. 2011. “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”. Journal of Uludağ University Medical Faculty 37 (3): 165-68. https://izlik.org/JA62JC44WJ.
EndNote
Avcı N, Manavoğlu O (September 1, 2011) How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Journal of Uludağ University Medical Faculty 37 3 165–168.
IEEE
[1]N. Avcı and O. Manavoğlu, “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”, Journal of Uludağ University Medical Faculty, vol. 37, no. 3, pp. 165–168, Sept. 2011, [Online]. Available: https://izlik.org/JA62JC44WJ
ISNAD
Avcı, Nilüfer - Manavoğlu, Osman. “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”. Journal of Uludağ University Medical Faculty 37/3 (September 1, 2011): 165-168. https://izlik.org/JA62JC44WJ.
JAMA
1.Avcı N, Manavoğlu O. How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Journal of Uludağ University Medical Faculty. 2011;37:165–168.
MLA
Avcı, Nilüfer, and Osman Manavoğlu. “How To Use Targeted Drugs in Metastatic Renal Cell Cancer”. Journal of Uludağ University Medical Faculty, vol. 37, no. 3, Sept. 2011, pp. 165-8, https://izlik.org/JA62JC44WJ.
Vancouver
1.Nilüfer Avcı, Osman Manavoğlu. How To Use Targeted Drugs in Metastatic Renal Cell Cancer. Journal of Uludağ University Medical Faculty [Internet]. 2011 Sep. 1;37(3):165-8. Available from: https://izlik.org/JA62JC44WJ